Manner D - Search Results

1

Bayesian methods for design and analysis of safety trials.

Price KL, Xia HA, Lakshminarayanan M, Madigan D, Manner D, Scott J, Stamey JD, Thompson L. Price KL, et al. Among authors: manner d. Pharm Stat. 2014 Jan-Feb;13(1):13-24. doi: 10.1002/pst.1586. Epub 2013 Jul 30. Pharm Stat. 2014. PMID: 23897858

2

Bayesian adaptive dose-finding studies with delayed responses.

Fu H, Manner D. Fu H, et al. Among authors: manner d. J Biopharm Stat. 2010 Sep;20(5):1055-70. doi: 10.1080/10543400903315740. J Biopharm Stat. 2010. PMID: 20721791

3

Perspectives on Some Controversies in Cardiovascular Disease Risk Assessment in the Pharmaceutical Development of Glucose-Lowering Medications.

Hoogwerf BJ, Manner DH, Fu H, Moscarelli E, Gaydos BL, Heine RJ. Hoogwerf BJ, et al. Among authors: manner dh. Diabetes Care. 2016 Aug;39 Suppl 2:S219-27. doi: 10.2337/dcS15-3025. Diabetes Care. 2016. PMID: 27440836 Review.

4

Restricted mean survival time for the analysis of cardiovascular outcome trials assessing non-inferiority: Case studies from antihyperglycemic drug development.

Manner DH, Battioui C, Hantel S, Beasley BN, Wei LJ, Geiger MJ, Turner JR, Abt M. Manner DH, et al. Am Heart J. 2019 Sep;215:178-186. doi: 10.1016/j.ahj.2019.05.016. Epub 2019 Jun 6. Am Heart J. 2019. PMID: 31349109 Review.

5

A clinical utility index for selecting an optimal insulin dosing algorithm for LY2605541 in patients with type 2 diabetes pretreated with basal insulin.

Manner DH, Luo J, Qu Y, Berry S, Gaydos BL, Jacober SJ. Manner DH, et al. Diabetes Technol Ther. 2014 Aug;16(8):499-505. doi: 10.1089/dia.2013.0268. Epub 2014 May 13. Diabetes Technol Ther. 2014. PMID: 24825416 Clinical Trial.

6

Diabetic microvascular complications: can patients at risk be identified? A review.

Girach A, Manner D, Porta M. Girach A, et al. Among authors: manner d. Int J Clin Pract. 2006 Nov;60(11):1471-83. doi: 10.1111/j.1742-1241.2006.01175.x. Int J Clin Pract. 2006. PMID: 17073842 Review.

7

Optimizing Drug Development Programs: Type 2 Diabetes Case Study.

Antonijevic Z, Kimber M, Manner D, Burman CF, Pinheiro J, Bergenheim K. Antonijevic Z, et al. Among authors: manner d. Ther Innov Regul Sci. 2013 May;47(3):363-374. doi: 10.1177/2168479013480501. Ther Innov Regul Sci. 2013. PMID: 30231431

8

A cross-sectional community-based observational study of asymptomatic SARS-CoV-2 prevalence in the greater Indianapolis area.

Meyers KJ, Jones ME, Goetz IA, Botros FT, Knorr J, Manner DH, Woodward B. Meyers KJ, et al. Among authors: manner dh. J Med Virol. 2020 Nov;92(11):2874-2879. doi: 10.1002/jmv.26182. Epub 2020 Jul 2. J Med Virol. 2020. PMID: 32543722 Free PMC article.

9

Follow-up of SARS-CoV-2 positive subgroup from the Asymptomatic novel CORonavirus iNFection study.

Meyers KJ, Dillman B, Williams C, Jiang J, Clifford N, Miller JL, Jones ME, Goetz IA, Botros FT, Knorr J, Manner DH, Woodward B. Meyers KJ, et al. Among authors: manner dh. J Med Virol. 2021 May;93(5):2925-2931. doi: 10.1002/jmv.26810. Epub 2021 Feb 1. J Med Virol. 2021. PMID: 33463731 Free PMC article.

10

Impact of high risk thrombophilia status on recurrence among children and adults with VTE: An observational multicenter cohort study.

Brüwer G, Limperger V, Kenet G, Klostermeier UC, Shneyder M, Degenhardt F, Finckh U, Heller C, Holzhauer S, Trappe R, Kentouche K, Knoefler R, Kurnik K, Krümpel A, Lauten M, Manner D, Mesters R, Junker R, Nowak-Göttl U. Brüwer G, et al. Among authors: manner d. Blood Cells Mol Dis. 2016 Nov;62:24-31. doi: 10.1016/j.bcmd.2016.10.024. Epub 2016 Nov 5. Blood Cells Mol Dis. 2016. PMID: 27838551

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page